Pulmonary Hypertension Trial, Recruiting (NCT06544148)

Pulmonary Hypertension Trial, Recruiting NCT06544148 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06544148 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older.
You must be a patient in the ICU who is on a breathing machine (ventilator) and whose doctors have already decided to use a special heart monitoring tube (called a pulmonary artery catheter) to track heart pressures and blood flow.

Who may not be able to join:

You have an electronic device in or on your chest, such as a pacemaker, or any metal implants in your chest.
You are known to be pregnant or are currently breastfeeding.
You have an open lung injury or a collapsed lung (a condition called pneumothorax).
You have open wounds, drainage tubes, burns, or skin rashes on the upper part of your chest.
The measurement around your chest is estimated to be smaller than 66 cm (about 26 inches) or larger than 134 cm (about 53 inches).
You have a known allergy to wound dressings or sticky materials, such as the gel used on stick-on electrodes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaspar F Bachmann, MD, Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Phone: +41 31 632 21 11

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06544148

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: +41 31 632 21 11

More information: https://clinicaltrials.gov/study/NCT06544148

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older.
You must be a patient in the ICU who is on a breathing machine (ventilator) and whose doctors have already decided to use a special heart monitoring tube (called a pulmonary artery catheter) to track heart pressures and blood flow.

Who may not be able to join:

You have an electronic device in or on your chest, such as a pacemaker, or any metal implants in your chest.
You are known to be pregnant or are currently breastfeeding.
You have an open lung injury or a collapsed lung (a condition called pneumothorax).
You have open wounds, drainage tubes, burns, or skin rashes on the upper part of your chest.
The measurement around your chest is estimated to be smaller than 66 cm (about 26 inches) or larger than 134 cm (about 53 inches).
You have a known allergy to wound dressings or sticky materials, such as the gel used on stick-on electrodes.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

5 August 2024

Est. completion

5 August 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Mean difference between EIT-derived and PAC-measured changes in pulmonary artery pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov